Skip to main content
WeightCited

5-HTP 관련 Appetite Control

C

Double-blind RCT (n=20) found 750 mg/day reduced caloric intake by 38% and produced greater weight loss (1.5 kg vs. +0.2 kg placebo) over 5 weeks. A 12-week crossover trial confirmed reduced carbohydrate and fat intake at 900 mg/day. Sample sizes are small but findings are mechanistically consistent.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dappetite\u002Dcontrol'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Double-blind RCT (n=20) found 750 mg/day reduced caloric intake by 38% and produced greater weight loss (1.5 kg vs. +0.2 kg placebo) over 5 weeks. A 12-week crossover trial confirmed reduced carbohydrate and fat intake at 900 mg/day. Sample sizes are small but findings are mechanistically consistent.

Key Statistics

4

연구

100

참여자

Positive

C

등급

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
50-100 mg 1-3x/day
starting:
50 mg/day and titrate up
appetitecontrol:
250-300 mg/day 30 min before meals

상한량: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

권장 복용 시간: 30 minutes before meals on an empty stomach

Safety & Side Effects

보고된 부작용

  • Nausea
  • Drowsiness
  • GI discomfort
  • Serotonin syndrome risk with contraindicated medications

알려진 상호작용

  • SSRIs (serotonin syndrome risk — NEVER combine)
  • SNRIs (serotonin syndrome risk — NEVER combine)
  • MAOIs (serotonin syndrome risk — NEVER combine)
  • Triptans (serotonin syndrome risk)
  • Carbidopa

일일 최대 섭취 허용량: 500 mg/day; avoid combining with SSRIs, SNRIs, MAOIs, or triptans (serotonin syndrome risk)

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 5-HTP help with Appetite Control?
Based on 4 studies with 100 participants, there is limited but promising evidence that 5-HTP may support Appetite Control management. Our evidence grade is C (Some Evidence).
How much 5-HTP should I take for Appetite Control?
Studies have used various dosages. A commonly studied range is 50-100 mg 1-3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Drowsiness, GI discomfort, Serotonin syndrome risk with contraindicated medications. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Appetite Control?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

5-HTP 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.